1. Home
  2. IFBD vs SILO Comparison

IFBD vs SILO Comparison

Compare IFBD & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Infobird Co. Ltd

IFBD

Infobird Co. Ltd

N/A

Current Price

$1.00

Market Cap

7.5M

Sector

Technology

ML Signal

N/A

Logo Silo Pharma Inc.

SILO

Silo Pharma Inc.

HOLD

Current Price

$2.52

Market Cap

379.7K

ML Signal

HOLD

Company Overview

Basic Information
Metric
IFBD
SILO
Founded
2001
2010
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Apparel
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.5M
379.7K
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
IFBD
SILO
Price
$1.00
$2.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.3K
51.3K
Earning Date
05-01-2023
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.98
EPS
N/A
N/A
Revenue
N/A
$72,102.00
Revenue This Year
N/A
$1.86
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$0.22
52 Week High
$2.18
$7.95

Technical Indicators

Market Signals
Indicator
IFBD
SILO
Relative Strength Index (RSI) 48.75 26.09
Support Level $0.99 $0.30
Resistance Level $1.10 $4.80
Average True Range (ATR) 0.08 0.24
MACD -0.01 0.00
Stochastic Oscillator 54.45 8.31

Price Performance

Historical Comparison
IFBD
SILO

About IFBD Infobird Co. Ltd

Infobird Co Ltd is a software-as-a-service (SaaS) provider of AI-powered customer engagement solutions in China. The Company provides standard and customized customer relationship management cloud-based services, including SaaS and business process outsourcing (BPO) services. It generates revenue from the development and sale of software licenses for customized software, as well as from business integration solution services and digital advertising and marketing campaign services. Digital advertising revenue is generated from developing and executing advertising plans based on customer needs, and the Company generally provides limited warranties for work performed under its business integration solution contracts. The Company generates maximum revenue from its operations in Mainland China.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.

Share on Social Networks: